“john-maraganore” Archives

in
Entry Author Date Location
Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston 07/31/19 National
Alnylam Gets $800M From Regeneron to Bring RNAi to Eye, Brain Diseases 04/08/19 Boston
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More 01/11/19 National
BIO Has Big Diversity Goals. Does It Have the Means to Reach Them? 10/11/18 National
Xconomy Awards 2018 Gala Honors the Best of Boston Life Science: Slideshow 10/11/18 Boston
The Winners of the 2018 Xconomy Awards Are… 09/05/18 Boston
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug 08/10/18 Boston
Down the Stretch: Akcea, Alnylam Face Reality Checks as FDA Dates Loom 07/06/18 Boston
The Art of Perseverance: Meet Xconomy’s Six CEO Award Finalists 07/02/18 Boston
The 2018 Xconomy Awards Finalists Are… 06/28/18 Boston
Take Two: Biotech Party with Nearly Nude Women Condemned by Industry Leaders 06/13/18 Boston
Brii Biosciences Debuts with a China Pharma Strategy Backed by $260M 05/24/18 Raleigh Durham
In Week of Hemophilia News, Alnylam Drug Cleared to Move Forward 12/15/17 Boston
Alnylam Data Puts a Nobel Discovery One Step Closer to Approved Drug 09/20/17 Boston
To Infinity and Beyond: Julian Adams on Missteps and His New Job 04/03/17 Boston
Harvard’s Verdine Aims to Retire, Become Full-Time FogPharma CEO 02/23/17 Boston
Biotech Leaders Sign Letter Condemning Trump’s Travel Ban 02/07/17 National
Alnylam Scraps RNAi Drug After Safety Problems, Shares Plunge 10/05/16 Boston
Making the Price Right: Ideas To Change Drug Costs Gain Momentum 04/05/16 National
CRISPR Hits Wall Street as Editas Bags $94M in IPO 02/02/16 Boston
Grail’s Discount, Pfizergan & Pricing Plans: Notes from the JPM Vortex 01/15/16 National
Celgene Cozies up to Nurix With $150M Drug Development Deal 09/16/15 San Francisco
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
Arrowhead’s Novartis RNAi Deal: Big Boost or ‘Stale Potato Chips’? 03/09/15 Wisconsin
Investors Line up For Westphal as Muscle Cramp Startup Upsizes IPO 01/28/15 Boston
East Coast Biotech Roundup: Alnylam, Stock Offerings, Curis, & More 01/23/15 Boston
Alnylam CEO: More Cash in Hand Is to Fuel Expansion From Within 01/21/15 Boston
14 for ’14: Xconomy’s Top Innovation Stories of the Year 12/29/14 National
Xconomy Boston’s Top Stories of Q3 2014: Editor’s Picks 10/01/14 Boston
East Coast Biotech Roundup: Maraganore, Flex, NPS, Retrophin, & More 09/15/14 Boston
Page 1 of 5 next page »